MASS — 908 Devices Inc.

Summary of 908 Devices Inc. Q4 2025 Earnings Call

1. Key Financial Results and Metrics:

• Q4 Revenue: $17.4 million, up 21% year-over-year from $14.3 million.
• Full-Year Revenue: $56.2 million, an 18% increase from $47.7 million in 2024.
• Adjusted EBITDA: Positive $700,000 in Q4, a significant improvement from a loss of $4 million in the prior year.
• Net Income: $4.4 million for 2025, compared to a net loss of $16 million in 2024.
• Recurring Revenue: Grew 22% year-over-year, representing 35% of total revenues in 2025.
• Cash Position: Ended 2025 with $113 million in cash, no debt.

2. Strategic Updates and Business Highlights:

• Product Performance: Strong demand for the Explorer gas identification device and initial success of the Viper product, which combines FTIR and Raman spectroscopy.
• Market Expansion: 27% of revenues came from international markets, up from 25% in 2024, with notable sales in NATO countries.
• Operational Improvements: Consolidation of manufacturing and headquarters has led to cost efficiencies and improved operational control.
• Strategic Partnerships: Partnered with Mountain Horse Solutions to streamline procurement for U.S. federal contracts, enhancing forecasting and logistics.

3. Forward Guidance and Outlook:

• 2026 Revenue Guidance: Expected to be between $64.5 million and $67.5 million, representing 15% to 20% growth over 2025.
• Handheld Product Revenue Growth: Projected to grow 13% to 17%, driven by the full-year impact of Viper and growth of the MX908.
• Adjusted Gross Margins: Targeting mid- to high-50% range with expected margin expansion of at least 100 basis points.
• Adjusted EBITDA Loss: Expected to be cut in half, targeting low- to mid-single-digit millions for 2026.

4. Bad News, Challenges, or Points of Concern:

• Federal Funding Uncertainty: The ongoing DHS funding issues could impact state and local grant applications, although overall funding dynamics are more favorable than the previous year.
• Market Risks: Potential geopolitical tensions, such as conflicts in the Middle East, could create uncertainties in federal and military spending.
• Operational Challenges: The company has to manage the transition to new products while ensuring existing product lines maintain performance.

5. Notable Q&A Insights:

• Mountain Horse Partnership: The consolidation to a single procurement partner aims to enhance efficiency and reduce complexity in federal contracting.
• Next-Gen MX908 Platform: Expected commercial launch later in 2026, with a focus on ensuring product readiness before broad commercialization.
• State and Local Market Focus: Investments in sales capabilities are expected to yield quicker returns compared to international markets, which may take longer to develop.
• Long-Term Growth Drivers: The FTIR replacement cycle is seen as a durable multiyear driver, with ongoing innovation expected to sustain growth beyond 2026.

Overall, 908 Devices Inc. demonstrated strong financial performance in 2025, driven by product innovation and strategic partnerships, while also outlining a positive growth outlook for 2026 despite some uncertainties in federal funding and geopolitical risks.